InvestorsHub Logo
Followers 6
Posts 330
Boards Moderated 0
Alias Born 02/06/2023

Re: None

Wednesday, 07/12/2023 11:33:56 AM

Wednesday, July 12, 2023 11:33:56 AM

Post# of 426689
Amarin receives US patent on next generation Vascepa-Plus. https://www.freepatentsonline.com/11690820.html

The unique feature here is what is potentially added: PPAR agonist (e.g. diabetes drug) plus arachidonic acid (AA) (Omega-6 fatty acid) plus other items plus an antioxidant. No mention of statins in this patent in the claim section.

Smart invention. Not something generics can copy if it's only approved for CVD and is Vascepa-PLUS.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News